| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1004906591 |
| P356 | DOI | 10.1007/S10616-010-9296-7 |
| P953 | full work available at URL | https://europepmc.org/articles/pmc2993866?pdf=render |
| https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20809260/?tool=EBI | ||
| https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20809260/pdf/?tool=EBI | ||
| https://europepmc.org/articles/PMC2993866 | ||
| https://europepmc.org/articles/PMC2993866?pdf=render | ||
| https://doi.org/10.1007/s10616-010-9296-7 | ||
| P932 | PMC publication ID | 2993866 |
| P698 | PubMed publication ID | 20809260 |
| P5875 | ResearchGate publication ID | 46109001 |
| P2093 | author name string | Zhijian Chen | |
| Yanjie You | |||
| Yonggang Ran | |||
| Jiongyu Chen | |||
| Chaoqun Hong | |||
| P2860 | cites work | The biology of VEGF and its receptors | Q27860704 |
| Phase II, randomized, placebo-controlled trial of neoadjuvant celecoxib in men with clinically localized prostate cancer: evaluation of drug-specific biomarkers | Q33561179 | ||
| Celecoxib-induced apoptosis is enhanced by ABT-737 and by inhibition of autophagy in human colorectal cancer cells | Q34168046 | ||
| Many actions of cyclooxygenase-2 in cellular dynamics and in cancer | Q34539982 | ||
| Cyclooxygenase 2 expression in nasopharyngeal carcinoma: immunohistochemical findings and potential implications | Q35588568 | ||
| Inhibition effect of pcDNA-tum-5 on the growth of S180 tumor. | Q36484817 | ||
| Cyclooxygenases, prostanoids, and tumor progression | Q36925833 | ||
| NSAIDs and breast cancer: a possible prevention and treatment strategy | Q37056712 | ||
| Current status of COX-2 inhibitors | Q37066819 | ||
| Cyclooxygenase-2 (COX-2) in carcinogenesis and selective COX-2 inhibitors for chemoprevention in gastrointestinal cancers | Q37334147 | ||
| Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung | Q37429876 | ||
| Selective cyclooxygenase-2 (COX-2) inhibitors used for preventing or regressing cancer | Q37516212 | ||
| COX-2, VEGF and tumour angiogenesis. | Q37542134 | ||
| Nonsteroidal antiinflammatory drugs and cyclooxygenase inhibition in the gastrointestinal tract: a trip from peptic ulcer to colon cancer | Q37579505 | ||
| Celecoxib potentiates the anticancer effect of cisplatin on vulvar cancer cells independently of cyclooxygenase | Q39805336 | ||
| Anti-gastric cancer effects of celecoxib, a selective COX-2 inhibitor, through inhibition of Akt signaling | Q39934730 | ||
| Radiosensitization of human glioma cells by cyclooxygenase-2 (COX-2) inhibition: independent on COX-2 expression and dependent on the COX-2 inhibitor and sequence of administration. | Q40087518 | ||
| Prostaglandin E2 induces vascular endothelial growth factor secretion in prostate cancer cells through EP2 receptor-mediated cAMP pathway | Q40146956 | ||
| Celecoxib induces dose dependent growth inhibition in nasopharyngeal carcinoma cell lines independent of cyclooxygenase-2 expression | Q40310448 | ||
| In vitro and in vivo effects and mechanisms of celecoxib-induced growth inhibition of human hepatocellular carcinoma cells | Q40349145 | ||
| Prediction of poor survival by cyclooxygenase-2 in patients with T4 nasopharyngeal cancer treated by radiation therapy: clinical and in vitro studies | Q40445725 | ||
| Effects of cyclooxygenase 2 inhibitors on biological traits of nasopharyngeal carcinoma cells. | Q40542922 | ||
| Potentiation of tumor response to radiation or chemoradiation by selective cyclooxygenase-2 enzyme inhibitors | Q44748389 | ||
| Fine mapping of the 11q22-23 tumor suppressive region and involvement of TSLC1 in nasopharyngeal carcinoma. | Q45069987 | ||
| Prostaglandin E2 induces vascular endothelial growth factor and basic fibroblast growth factor mRNA expression in cultured rat Müller cells. | Q46298904 | ||
| Neoadjuvant therapy with celecoxib to women with early stage breast cancer. | Q46780681 | ||
| Anti-angiogenic effects of Hypericin-photodynamic therapy in combination with Celebrex in the treatment of human nasopharyngeal carcinoma. | Q46793271 | ||
| Overexpression of cyclooxygenase-2 in nasopharyngeal carcinoma and association with lymph node metastasis. | Q53355815 | ||
| Celecoxib reduces microvessel density in patients treated with nasopharyngeal carcinoma and induces changes in gene expression. | Q53596494 | ||
| Radiosensitivity enhancement by combined treatment of celecoxib and gefitinib on human lung cancer cells. | Q53604800 | ||
| A phase I/II trial of celecoxib with chemotherapy and radiotherapy in the treatment of patients with locally advanced oesophageal cancer | Q60685892 | ||
| Efficacy and patterns of failure for locally advanced cancer of the cervix treated with celebrex (celecoxib) and chemoradiotherapy in RTOG 0128 | Q80271882 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 431-438 | |
| P577 | publication date | 2010-09-01 | |
| P1433 | published in | Cytotechnology | Q15752151 |
| P1476 | title | Anti-cancer effects of celecoxib on nasopharyngeal carcinoma HNE-1 cells expressing COX-2 oncoprotein | |
| P478 | volume | 62 |
| Q50938316 | An in vitro model for spontaneous angiogenesis using rat mesenteric endothelial cells: possible therapeutic perspective for obesity and related disorders. |
| Q50893711 | Celecoxib and fish oil: a combination strategy for decreased inflammatory mediators in early stages of experimental mammary cancer. |
| Q33567401 | Celecoxib induces apoptosis and cell-cycle arrest in nasopharyngeal carcinoma cell lines via inhibition of STAT3 phosphorylation |
| Q38489938 | Combining antiangiogenic therapy and radiation in nasopharyngeal carcinoma |
| Q90333146 | Over-expression of cyclo-oxygenase-2 predicts poor survival of patients with nasopharyngeal carcinoma: a meta-analysis |
| Q45751366 | Prognostic significance of expression of cyclooxygenase-2, vascular endothelial growth factor, and epidermal growth factor receptor in nasopharyngeal carcinoma. |
| Q99565944 | Targeting fatty acid synthase sensitizes human nasopharyngeal carcinoma cells to radiation via downregulating frizzled class receptor 10 |
| Q37456696 | The enhancement of radiosensitivity in human esophageal squamous cell carcinoma cells by zoledronic acid and its potential mechanism |
Search more.